Skip to main content

Advertisement

Table 3 Baseline characteristics of the 101 hypertensive patients with or without arterial stiffness

From: Low serum adiponectin level is associated with metabolic syndrome and is an independent marker of peripheral arterial stiffness in hypertensive patients

Characteristic Low arterial stiffness group (%) High arterial stiffness group (%) P value
Gender
 Male 19 (65.5) 48 (66.7) 0.912
 Female 10 (34.5) 24 (33.3)
Diabetes
 No 21 (72.4) 36 (50.0) <0.001*
 Yes 8 (27.6) 36 (50.0)
Metabolic syndrome
 No 22 (75.9) 16 (22.2) <0.001*
 Yes 7 (24.1) 56 (77.8)
ACE inhibitor use
 No 17 (58.6) 47 (65.3) 0.530
 Yes 12 (41.4) 25 (34.7)
ARB use
 No 14 (48.3) 31 (43.1) 0.633
 Yes 15 (51.7) 41 (56.9)
β-blocker use
 No 12 (41.4) 33 (45.8) 0.684
 Yes 17 (58.6) 39 (54.2)
CCB use
 No 15 (51.7) 42 (58.3) 0.544
 Yes 14 (48.3) 30 (41.7)
Thiazide use
 No 23 (78.3) 57 (79.2) 0.987
 Yes 6 (20.7) 5 (20.8)
Statin
 No 12 (41.4) 31 (43.1) 0.877
 Yes 17 (58.6) 35 (56.9)  
Fibrate
 No 23 (79.3) 64 (88.9) 0.208
 Yes 6 (20.7) 5 (11.3)  
  1. Data are expressed as number of patients and analysis was performed by using the Chi square test
  2. ARB angiotensin-receptor blocker, ACE angiotensin-converting enzyme, CCB calcium-channel blocker
  3. * P < 0.05 was considered statistically significant